CD19-Targeted Chimeric Antigen Receptor T Cell Therapy in Two Patients with Multiple Sclerosis

Scientists report the first individual treatment with a fully human CD19 CAR-T cell therapy in two patients with progressive multiple sclerosis. CD19 CAR-T cell administration resulted in acceptable safety profiles for both patients.
Full ArticleGraphical Abstract